313 related articles for article (PubMed ID: 16109776)
21. Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML).
Thiede C; Koch S; Creutzig E; Steudel C; Illmer T; Schaich M; Ehninger G
Blood; 2006 May; 107(10):4011-20. PubMed ID: 16455956
[TBL] [Abstract][Full Text] [Related]
22. Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia.
Schlenk RF; Döhner K; Krauter J; Fröhling S; Corbacioglu A; Bullinger L; Habdank M; Späth D; Morgan M; Benner A; Schlegelberger B; Heil G; Ganser A; Döhner H;
N Engl J Med; 2008 May; 358(18):1909-18. PubMed ID: 18450602
[TBL] [Abstract][Full Text] [Related]
23. Acute myeloid leukemia carrying cytoplasmic/mutated nucleophosmin (NPMc+ AML): biologic and clinical features.
Falini B; Nicoletti I; Martelli MF; Mecucci C
Blood; 2007 Feb; 109(3):874-85. PubMed ID: 17008539
[TBL] [Abstract][Full Text] [Related]
24. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia.
; Ley TJ; Miller C; Ding L; Raphael BJ; Mungall AJ; Robertson A; Hoadley K; Triche TJ; Laird PW; Baty JD; Fulton LL; Fulton R; Heath SE; Kalicki-Veizer J; Kandoth C; Klco JM; Koboldt DC; Kanchi KL; Kulkarni S; Lamprecht TL; Larson DE; Lin L; Lu C; McLellan MD; McMichael JF; Payton J; Schmidt H; Spencer DH; Tomasson MH; Wallis JW; Wartman LD; Watson MA; Welch J; Wendl MC; Ally A; Balasundaram M; Birol I; Butterfield Y; Chiu R; Chu A; Chuah E; Chun HJ; Corbett R; Dhalla N; Guin R; He A; Hirst C; Hirst M; Holt RA; Jones S; Karsan A; Lee D; Li HI; Marra MA; Mayo M; Moore RA; Mungall K; Parker J; Pleasance E; Plettner P; Schein J; Stoll D; Swanson L; Tam A; Thiessen N; Varhol R; Wye N; Zhao Y; Gabriel S; Getz G; Sougnez C; Zou L; Leiserson MD; Vandin F; Wu HT; Applebaum F; Baylin SB; Akbani R; Broom BM; Chen K; Motter TC; Nguyen K; Weinstein JN; Zhang N; Ferguson ML; Adams C; Black A; Bowen J; Gastier-Foster J; Grossman T; Lichtenberg T; Wise L; Davidsen T; Demchok JA; Shaw KR; Sheth M; Sofia HJ; Yang L; Downing JR; Eley G
N Engl J Med; 2013 May; 368(22):2059-74. PubMed ID: 23634996
[TBL] [Abstract][Full Text] [Related]
25. Prognostic relevance of integrated genetic profiling in acute myeloid leukemia.
Patel JP; Gönen M; Figueroa ME; Fernandez H; Sun Z; Racevskis J; Van Vlierberghe P; Dolgalev I; Thomas S; Aminova O; Huberman K; Cheng J; Viale A; Socci ND; Heguy A; Cherry A; Vance G; Higgins RR; Ketterling RP; Gallagher RE; Litzow M; van den Brink MR; Lazarus HM; Rowe JM; Luger S; Ferrando A; Paietta E; Tallman MS; Melnick A; Abdel-Wahab O; Levine RL
N Engl J Med; 2012 Mar; 366(12):1079-89. PubMed ID: 22417203
[TBL] [Abstract][Full Text] [Related]
26. Biological and clinical consequences of NPM1 mutations in AML.
Heath EM; Chan SM; Minden MD; Murphy T; Shlush LI; Schimmer AD
Leukemia; 2017 Apr; 31(4):798-807. PubMed ID: 28111462
[TBL] [Abstract][Full Text] [Related]
27. The impact of FLT3 internal tandem duplication mutant level, number, size, and interaction with NPM1 mutations in a large cohort of young adult patients with acute myeloid leukemia.
Gale RE; Green C; Allen C; Mead AJ; Burnett AK; Hills RK; Linch DC;
Blood; 2008 Mar; 111(5):2776-84. PubMed ID: 17957027
[TBL] [Abstract][Full Text] [Related]
28. Favorable prognostic impact of NPM1 mutations in older patients with cytogenetically normal de novo acute myeloid leukemia and associated gene- and microRNA-expression signatures: a Cancer and Leukemia Group B study.
Becker H; Marcucci G; Maharry K; Radmacher MD; Mrózek K; Margeson D; Whitman SP; Wu YZ; Schwind S; Paschka P; Powell BL; Carter TH; Kolitz JE; Wetzler M; Carroll AJ; Baer MR; Caligiuri MA; Larson RA; Bloomfield CD
J Clin Oncol; 2010 Feb; 28(4):596-604. PubMed ID: 20026798
[TBL] [Abstract][Full Text] [Related]
29. IDH1 and IDH2 gene mutations identify novel molecular subsets within de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study.
Marcucci G; Maharry K; Wu YZ; Radmacher MD; Mrózek K; Margeson D; Holland KB; Whitman SP; Becker H; Schwind S; Metzeler KH; Powell BL; Carter TH; Kolitz JE; Wetzler M; Carroll AJ; Baer MR; Caligiuri MA; Larson RA; Bloomfield CD
J Clin Oncol; 2010 May; 28(14):2348-55. PubMed ID: 20368543
[TBL] [Abstract][Full Text] [Related]
30. Internal tandem duplication of the flt3 gene found in acute myeloid leukemia.
Nakao M; Yokota S; Iwai T; Kaneko H; Horiike S; Kashima K; Sonoda Y; Fujimoto T; Misawa S
Leukemia; 1996 Dec; 10(12):1911-8. PubMed ID: 8946930
[TBL] [Abstract][Full Text] [Related]
31. IDH1 and IDH2 mutations are frequent genetic alterations in acute myeloid leukemia and confer adverse prognosis in cytogenetically normal acute myeloid leukemia with NPM1 mutation without FLT3 internal tandem duplication.
Paschka P; Schlenk RF; Gaidzik VI; Habdank M; Krönke J; Bullinger L; Späth D; Kayser S; Zucknick M; Götze K; Horst HA; Germing U; Döhner H; Döhner K
J Clin Oncol; 2010 Aug; 28(22):3636-43. PubMed ID: 20567020
[TBL] [Abstract][Full Text] [Related]
32. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.
Arber DA; Orazi A; Hasserjian R; Thiele J; Borowitz MJ; Le Beau MM; Bloomfield CD; Cazzola M; Vardiman JW
Blood; 2016 May; 127(20):2391-405. PubMed ID: 27069254
[TBL] [Abstract][Full Text] [Related]
33. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet.
Döhner H; Estey EH; Amadori S; Appelbaum FR; Büchner T; Burnett AK; Dombret H; Fenaux P; Grimwade D; Larson RA; Lo-Coco F; Naoe T; Niederwieser D; Ossenkoppele GJ; Sanz MA; Sierra J; Tallman MS; Löwenberg B; Bloomfield CD;
Blood; 2010 Jan; 115(3):453-74. PubMed ID: 19880497
[TBL] [Abstract][Full Text] [Related]
34. Nucleophosmin (NPM1) mutations in adult and childhood acute myeloid leukaemia: towards definition of a new leukaemia entity.
Rau R; Brown P
Hematol Oncol; 2009 Dec; 27(4):171-81. PubMed ID: 19569254
[TBL] [Abstract][Full Text] [Related]
35. Acute myeloid leukemia with mutated NPM1: diagnosis, prognosis and therapeutic perspectives.
Falini B; Sportoletti P; Martelli MP
Curr Opin Oncol; 2009 Nov; 21(6):573-81. PubMed ID: 19770764
[TBL] [Abstract][Full Text] [Related]
36. Acute myeloid leukemia with mutated nucleophosmin (NPM1): is it a distinct entity?
Falini B; Martelli MP; Bolli N; Sportoletti P; Liso A; Tiacci E; Haferlach T
Blood; 2011 Jan; 117(4):1109-20. PubMed ID: 21030560
[TBL] [Abstract][Full Text] [Related]
37. Prognostic significance of CEBPA mutations in a large cohort of younger adult patients with acute myeloid leukemia: impact of double CEBPA mutations and the interaction with FLT3 and NPM1 mutations.
Green CL; Koo KK; Hills RK; Burnett AK; Linch DC; Gale RE
J Clin Oncol; 2010 Jun; 28(16):2739-47. PubMed ID: 20439648
[TBL] [Abstract][Full Text] [Related]
38. FLT3 D835/I836 mutations are associated with poor disease-free survival and a distinct gene-expression signature among younger adults with de novo cytogenetically normal acute myeloid leukemia lacking FLT3 internal tandem duplications.
Whitman SP; Ruppert AS; Radmacher MD; Mrózek K; Paschka P; Langer C; Baldus CD; Wen J; Racke F; Powell BL; Kolitz JE; Larson RA; Caligiuri MA; Marcucci G; Bloomfield CD
Blood; 2008 Feb; 111(3):1552-9. PubMed ID: 17940205
[TBL] [Abstract][Full Text] [Related]
39. The origin and evolution of mutations in acute myeloid leukemia.
Welch JS; Ley TJ; Link DC; Miller CA; Larson DE; Koboldt DC; Wartman LD; Lamprecht TL; Liu F; Xia J; Kandoth C; Fulton RS; McLellan MD; Dooling DJ; Wallis JW; Chen K; Harris CC; Schmidt HK; Kalicki-Veizer JM; Lu C; Zhang Q; Lin L; O'Laughlin MD; McMichael JF; Delehaunty KD; Fulton LA; Magrini VJ; McGrath SD; Demeter RT; Vickery TL; Hundal J; Cook LL; Swift GW; Reed JP; Alldredge PA; Wylie TN; Walker JR; Watson MA; Heath SE; Shannon WD; Varghese N; Nagarajan R; Payton JE; Baty JD; Kulkarni S; Klco JM; Tomasson MH; Westervelt P; Walter MJ; Graubert TA; DiPersio JF; Ding L; Mardis ER; Wilson RK
Cell; 2012 Jul; 150(2):264-78. PubMed ID: 22817890
[TBL] [Abstract][Full Text] [Related]
40. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel.
Döhner H; Estey E; Grimwade D; Amadori S; Appelbaum FR; Büchner T; Dombret H; Ebert BL; Fenaux P; Larson RA; Levine RL; Lo-Coco F; Naoe T; Niederwieser D; Ossenkoppele GJ; Sanz M; Sierra J; Tallman MS; Tien HF; Wei AH; Löwenberg B; Bloomfield CD
Blood; 2017 Jan; 129(4):424-447. PubMed ID: 27895058
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
